Q3 Review: Analysing Aarti Drugs' Report Card | BQ Prime

#Q3WithBQ | #AartiDrugs' profit slides 37% year-on-year as formulation and specialty chemicals see revenue contraction.In conversation with CFO Adhish P Patil. #BQLive